Answers are grounded in this paper and cite their sources.
Parkinson disease is a complex neurodegenerative disease with both motor and nonmotor symptoms. Levodopa remains the mainstay of therapy but is associated with motor complications as the disease progresses. A levodopa-sparing strategy may reduce or delay the onset of motor complications. New medical and surgical therapies offer improved control of motor complications in advancing disease. Recognition and treatment of nonmotor symptoms can improve quality of life throughout the course of the disease.
No takes yet. Share an insight, caveat, or question.
Monique Giroux (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: